Trials / Conditions / EGFR G719X
EGFR G719X
3 registered clinical trials studyying EGFR G719X — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations NCT06517953 | Sun Yat-sen University | Phase 2 |
| Not Yet Recruiting | Study to Evaluate SBRT for EGFR Mutant NSCLC Patients Receiving Osimertinib (CULTRO) NCT05998993 | Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo | N/A |
| Unknown | First-line Furmonertinib in Advanced NSCLC Patients With EGFR Uncommon Mutation NCT05548348 | Chongqing University Cancer Hospital | Phase 2 |